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Infrainguinal bypass is associated with lower
perioperative mortality than major amputation in
high-risk surgical candidates
Neal R. Barshes, MD, MPH, Matthew T. Menard, MD, Louis L. Nguyen, MD, MBA, MPH,
Richard Bafford, MD, MSPH, C. Keith Ozaki, MD, and Michael Belkin, MD, Boston, Mass
Background:Major amputation is often selected over infrainguinal bypass in patients with severe systemic comorbidities
because it is assumed to have lower perioperative risks, yet this assumption is unproven and largely unexamined.
Methods:The2005 to 2008National SurgicalQuality ImprovementProject (NSQIP) databasewas used to identify all patients
undergoing either infrainguinal bypass or major amputation using procedural codes. Patients with systemic or local infections
were excluded. A subset of high-risk patients were then defined as American Society of Anesthesiologists (ASA) class 4 or 5, or
ASA class 3 with renal failure, dyspnea at rest, ventilator dependence, recent congestive heart failure, or recent myocardial
infarct. Propensity score matching was used to obtain two high-risk patient groups matched for preoperative characteristics.
Results:No significant differences in demographic, preoperative, or anesthetic variables were found between the matched,
high-risk amputation or bypass groups (792 and 780 patients, respectively). Bypass was associated with a lower 30-day
postoperative mortality than amputation (6.54% vs 9.97%; P  .0147). Amputation was associated with higher rates of
pulmonary embolism (0.9% vs 0% for amputation vs bypass groups, respectively; P  .009) and urinary tract infection
(5.2% vs 2.7%; P  .01), while bypass was associated with higher rates of return to the operating room (14.1% vs 27.6%;
P< .001) and a trend toward higher postoperative transfusion requirements (0.9% vs 2.1%; P .054). The postoperative
time to discharge did not differ between the two groups.
Conclusion: The decision to perform an infrainguinal bypass or amputation should depend on well-established predictors
of graft patency and functional success rather than presumptions about different perioperative risks between the two
procedures. ( J Vasc Surg 2011;53:1251-9.)
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MPeripheral arterial disease affects approximately 5 mil-
lion people in the United States. Non-Hispanic blacks,
diabetics, and the elderly seem disproportionately affected,
with prevalence rates of 7.9%, 10.8%, and 14.5% in these
groups, respectively. With an increasing incidence of diabe-
tes mellitus and increasing numbers of elderly patients, the
prevalence of peripheral arterial disease is expected to in-
crease as well.1 For patients with critical limb ischemia due
to lower extremity (ie, infrainguinal) occlusive disease,
open revascularization remains the most effective means of
achieving limb salvage. Lower extremity revascularization
can achieve limb salvage (preservation of the foot allowing
ambulation without a prosthetic2) in 88% of patients,3 and
meta-analysis of three major randomized trials of infrain-
guinal bypass had a mortality rate of 2.7%.4 Furthermore,
From the Division of Vascular and Endovascular Surgery, Department of
Surgery, Brigham and Women’s Hospital.
Conflicts of interest: none.
Additional material for this article may be found online at www.jvascsurg.org.
Presented at the 2010 Vascular Annual Meeting of the Society for Vascular
Surgery, Boston, Mass, June 10-13, 2010.
Reprint requests: Michael Belkin, MD, Professor and Chief, Division of
Vascular and Endovascular Surgery, Department of Surgery, Brigham and
Women’s Hospital, 75 Francis Street, Boston, MA 02215 (e-mail:
mbelkin@partners.org).
The editors and reviewers of this article have no relevant financial relationships
to disclose per the JVS policy that requires reviewers to decline review of any
manuscript for which they may have a competition of interest.
0741-5214/$36.00
Copyright © 2011 Published by Elsevier Inc. on behalf of the Society forc
Vascular Surgery.
doi:10.1016/j.jvs.2010.11.099here is some evidence that a successful attempt at revascu-
arization may be associated with lower hospital costs than
rimary amputation.5
Lower extremity amputation, on the other hand, is
ypically reserved for patients who are considered poor
ypass candidates for a host of reasons, including inade-
uate distal target vessels, failed previous attempts at revas-
ularization, poor functional status, or the presence of
ultiple severe medical comorbidities.6 Indeed, of the
00,000 patients in theUnited States that present each year
ith critical limb ischemia, approximately 25%will undergo
mputation without an attempt at revascularization. Esti-
ates of the perioperative mortality rate for major ampu-
ation (defined as any amputation that does not preserve at
east part of the foot) range from 6% to 17%.7-10 While this
igh rate is often attributed to the presence of multiple
evere systemic comorbidities,1,11 a risk-adjusted compari-
on of the perioperative mortality and morbidity of infrain-
uinal bypass and major amputation has not been done.
The objective of the current study was to perform a
isk-adjusted comparison of the early (30 day) postoperative
orbidity and mortality of infrainguinal bypass with major
mputation in a patient population with multiple severe, sys-
emic comorbidities to determine if primary amputation
ould indeedoffer a survival benefit amonghigh-risk patients.
ETHODS
Study subjects. This study represents a retrospective
ohort study based on the American College of Surgeons
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database from private sector (ie, non-Veteran’s Administra-
tion) hospitals. Data from the 2005 to 2008 NSQIP data-
base were used to identify patients that underwent infrain-
guinal bypass (using prosthetic or autologous conduit) and
patients that underwent major amputation (defined as
above-knee or below-knee amputation). These were iden-
tified based on Common Procedural Terminology codes
(Appendix, online only). This study was approved by the
Partners Human Research Committee under Protocol
#2009-P-002571/1.
Our ultimate goal was to identify two comparable
cohorts of patients who had undergone infrainguinal by-
pass or major lower extremity amputation but who might
be considered candidates for either procedure. To avoid
inclusion of patients who would have had a strong contra-
indication toward revascularization attempts because of
wet gangrene (and thus were candidates only for major
amputation), we excluded all patients categorized as having
preoperative bacteremia, sepsis, or septic shock, or any
patient whose operative site was classified as infected or
dirty.
Next, a subset of high-risk patients was identified.
Criteria to define high-risk surgical candidates consisted of
the following:
● Any patient that was classified as American Society of
Anesthesiologists Physical Status Classification 4 (ASA
4, severe systemic disease that is a constant threat to
life) or ASA 5 (a moribund patient who is not expected
to survive without the operation).12
● Any patient classified as ASA 3 (a patient with severe
systemic disease) was included if one or more of the
following was also present: congestive heart failure exac-
erbation within the past 30 days; myocardial infarct
within the past 6 months; history of angina within 30
days of surgery; dyspnea at rest; mechanical ventilator
dependence before the operation; or renal failure (serum
creatinine3.0 mg/dL, or dialysis dependence).
Secondary analysis was performed using a subset of the
above-described high-risk study group. This subset in-
cluded only patients classified as having gangrene or rest
pain and excluded patients with complete functional de-
pendence (ie, no ability to independently perform activities
of daily living), and/or those classified as ASA 5. Propensity
scoring was again used to obtain two groups matched for
demographic, preoperative, and perioperative characteris-
tics, and again yielded two comparable groups lacking in
significant or important differences.
Propensity matching. A nonparsimonious logistic re-
gression analysis model was created to estimate the likeli-
hood of undergoing amputation or infrainguinal bypass
given various preoperative clinical and demographic char-
acteristics. The model was created using backward stepwise
regression using a P  .05 level. A propensity score was
then created from the final model and used to stratify
patients into quintiles. A random subset of patients were
selected from each of the five stratum, as according to wubin,13 to create two propensity-matched groups with
imilar preoperative characteristics and differing only by the
reatment option the subject underwent.
Statistical analysis. Survival was estimated using the
aplan-Meier product-limit estimate, and comparisons be-
ween survival functions were made with the log-rank test.
roup differences were further compared using the 2 test
or categorical variables and the nonparametric Mann–
hitney U test for continuous variables. Time from oper-
tion to discharge was analyzed using Kaplan-Meier esti-
ates; deaths within 30 days of the operation were counted
s censored observations. SPSS version 11.0 (SPSS Corpo-
ation, Chicago, Ill) and Intercooled Stata version 8.2
StataCorp, College Station, Tex) were used for all statisti-
al analyses and graphing. A P value of  .05 was consid-
red statistically significant.
ESULTS
Baseline characteristics of patients undergoing am-
utation and bypass. Between 2005 and 2008, a total of
105 patients who underwent major amputation and 1943
ho underwent infrainguinal bypass met the defined crite-
ia to be considered high-risk. These patients differed sig-
ificantly in many characteristics; these characteristics are
ummarized in Table I. Compared to the infrainguinal
ypass patients, major amputation patients weremore likely
o have had do-not-resuscitate orders (9.1% vs 1.7% for the
mputation vs bypass groups, respectively; P  .0001),
egional anesthesia (19.1% vs 10.4%, respectively; P 
001), insulin-dependent diabetes mellitus (52.0% vs
3.5%, respectively; P  .001), history of cerebrovascular
ccident with residual defect (19.1% vs 10.6%; P  .001),
nd pneumonia (3.1% vs 0.9%, respectively; P  .001).
mputation patients were less likely to have had previous
ercutaneous coronary intervention (18.4% vs 26.1%; P 
001), previous cardiac surgery (31.2% vs 37.4%, respec-
ively; P  .001), or non-insulin-dependent diabetes
13.8% vs 21.1%, respectively; P  .001). Finally, patients
ho had major amputations were more often of African
merican descent than patients who had infrainguinal by-
ass (25.1% vs 19.2%, respectively; P .001). Other statis-
ically significant differences with smaller absolute differ-
nces in prevalence are listed in Table I. The 30-day survival
ates were 88.29% for the nonmatched high-risk amputa-
ion group and 94.85% for the nonmatched high-risk by-
ass group (P  .0001).
Baseline characteristics of propensity-matched
ohorts. Propensity matching resulted in two matched
ohorts containing 792 patients who had a major amputa-
ion and 781 patients who had an infrainguinal bypass.
aseline characteristics for these patients did not differ
ignificantly in any of the 36 variables listed in Table II. Of
he patients in the major amputation group, 366 (46.2%)
nderwent above-knee amputations and 426 (53.8%) un-
erwent below-knee amputations. Of the patients in the
nfrainguinal bypass group, 366 patients (46.9%) under-
ent femoropopliteal bypass, 322 patients (41.3%) under-
ent femorotibial or femoroperoneal bypass, and 92 pa-
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Volume 53, Number 5 Barshes et al 1253tients (11.8%) underwent distal origin graft creation (Table
III shows further details). The median duration of anesthe-
sia was 2 hours for major amputation and 4 hours 48
minutes for patients receiving infrainguinal bypass.
Perioperative morbidity and mortality of the
propensity-matched cohorts. Comparison of the two
groups demonstrated that infrainguinal bypass was associ-
ated with significantly better 30-day survival than major
amputation in high-risk surgical candidates (93.46% vs
90.03%; P  .0147; Fig 1). Amputation was associated
with significantly higher rates of pulmonary embolism
(0.9% vs 0% for amputation vs bypass groups, respectively;
P .009) and urinary tract infection (5.2% vs 2.7%, respec-
Table I. Comparison of demographic and preoperative ch
1105) and bypass (n  1943) patients
Variable
Age
65 years old
65-74 years old
75-89 years old
90  years old
Race/ethnicity
White
African American
Hispanic
Asian, Native American, other
Male gender
CHF within 30 days before operation
MI within 6 months before operation
Angina within 1 month before operation
Previous percutaneous coronary intervention
Previous cardiac surgery
Ventilator dependence, preoperatively
Dyspnea at rest
History of severe COPD
Pneumonia
Serum creatinine 3 mg/dL
Dialysis
Acute renal failure
Non-insulin-dependent diabetes
Insulin-dependent diabetes
History of smoking within 1 year preoperatively
History of CVA with residual deficit
Partial or complete functional dependence before current illness
DNR, preoperatively
Obese (BMI 30 kg/m2)
Chronic steroid use
Weight loss 10% during 6 months before operation
ASA classification
ASA 3
ASA 4
ASA 5
ASA n  E
Anesthetic technique
General anesthesia
Regional anesthesia
ASA, American Society of Anesthesiologists; BMI, body mass index; CHF
cardiovascular accident; DNR, do not resuscitate; MI, myocardial infarction
aP  .05.
bP  .01.tively; P  .01), while bypass was associated with signifi- 5antly higher rates of return to odds ratio (14.1% vs 27.6%,
espectively; P .001) and a trend toward higher bleeding
vents requiring transfusion (0.9% vs 2.1%, P .054; Table
V). The median postoperative length of stay was 6 days for
atients receiving amputation and 7 days for patients re-
eiving bypass surgery. As demonstrated in Fig 2, there was
o significant difference in the time from operation to
ischarge (P  .21).
Comparison of the critical limb ischemia subset.
ropensity matching for the subset of patients denoted as
aving critical limb ischemia and excluding patients with
omplete functional dependence or that were classified as
SA 5 yielded 500 patients with major amputations and
eristics for nonstratified high-risk amputation (n 
Amputation group No.
(%)
Bypass group No.
(%) P value
387 (35.1) 624 (32.1) .09
292 (26.5) 582 (29.9) .04a
377 (34.2) 691 (35.5) .45
46 (4.2) 46 (2.3) .005b
692 (62.8) 1322 (68.0) .003b
277 (25.1) 373 (19.2) .001b
59 (5.3) 111 (5.7) .68
74 (6.7) 137 (7.1) .73
687 (62.3) 1213 (62.4) .96
138 (12.5) 208 (10.7) .13
105 (9.5) 152 (7.8) .10
30 (2.7) 90 (4.6) .009b
203 (18.4) 508 (26.1) .001b
344 (31.2) 727 (37.4) .001b
33 (3.0) 18 (0.9) .001
79 (7.2) 163 (8.4) .23
192 (17.4) 401 (20.6) .03a
34 (3.1) 18 (0.9) .001b
357 (32.4) 500 (25.7) .001b
386 (35.0) 499 (25.7) .001b
52 (4.7) 87 (4.5) .76
152 (13.8) 410 (21.1) .001b
573 (52.0) 651 (33.5) .001b
267 (24.2) 648 (33.3) .001b
211 (19.1) 206 (10.6) .001b
546 (49.0) 339 (17.4) .001b
100 (9.1) 33 (1.7) .0001b
292 (26.5) 498 (25.6) .60
83 (7.5) 111 (5.7) .048a
44 (4.0) 47 (2.4) .014b
254 (23.0) 542 (27.9) .003b
833 (75.6) 1379 (70.9) .006b
8 (0.7) 8 (0.4) .25
103 (9.3) 162 (8.3) .34
881 (79.9) 1720 (88.5) .001b
210 (19.1) 202 (10.4) .001b
estive heart failure; COPD, chronic obstructive pulmonary disease; CVA,aract
, cong
.05 patients with infrainguinal bypass. Again, baseline
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May 20111254 Barshes et alcharacteristics for these patients did not differ significantly
in any of 36 variables (Table V). Comparison of these two
groups demonstrated 30-day survival rates that were nearly
identical to that of the larger propensity-matched high-risk
Table II. Comparison of demographic and preoperative c
(n  781) patients matched by propensity scoring
Variable
Age
65 years old
65-74 years old
75-89 years old
90  years old
Race/ethnicity
White
African American
Hispanic
Asian, Native American, other
Male gender
CHF within 30 days before operation
MI within 6 months before operation
Angina within 1 month before operation
Previous PCI
Previous cardiac surgery
Ventilator dependence, preoperatively
Dyspnea at rest
History of severe COPD
Current pneumonia, preoperatively
Serum creatinine 3 mg/dL
Dialysis
Acute renal failure
Non-insulin-dependent diabetes
Insulin-dependent diabetes
History of smoking within 1 year preoperatively
History of CVA with residual deficit
Partial or complete functional dependence before current illness
DNR, preoperatively
Obese (BMI 30 kg/m2)
Chronic steroid use
Weight loss 10% during 6 months before operation
ASA classification
ASA 3
ASA 4
ASA 5
ASA n  E
Anesthetic technique
General anesthesia
Regional anesthesia
ASA, American Society of Anesthesiologists; BMI, body mass index; CHF
cardiovascular accident; DNR, do not resuscitate; MI, myocardial infarction
Table III. Primary procedures performed in the high-risk
780)
Procedure Vein condui
Femoropopliteal bypass 182 (23.3%
Femorotibial or femoroperoneal 245 (31.4%
Distal origin grafts 83 (10.6%
Total 507 (65.3%
PTFE, Polytetrafluoroethylene.study group, with a trend toward better survival among the datients receiving bypass (93.86% vs 90.60%; P  .0557;
ig 3). The median postoperative length of stay was 6 days
or both the patients who received amputation and those who
ad a bypass, and the time fromoperation to discharge did not
teristics for high-risk amputation (n  792) and bypass
Amputation group No.
(%)
Bypass group No.
(%) P value
286 (36.1) 278 (35.6) .85
212 (26.8) 209 (26.8) .99
272 (34.3) 271 (34.7) .87
22 (2.8) 22 (2.8) .96
507 (64.0) 488 (62.6) .55
189 (23.9) 187 (24.0) .96
43 (5.4) 52 (6.7) .30
53 (6.7) 53 (6.8) .94
493 (62.2) 489 (62.7) .86
98 (12.4) 92 (11.8) .73
67 (8.5) 70 (9.0) .72
26 (3.3) 18 (2.3) .24
164 (20.7) 159 (20.4) .87
269 (34.0) 259 (33.2) .75
18 (2.3) 16 (2.1) .76
63 (8.0) 57 (7.3) .63
142 (17.9) 142 (18.2) .89
20 (2.5) 11 (1.4) .11
248 (31.3) 250 (32.1) .75
254 (32.1) 265 (34.0) .45
37 (4.7) 34 (4.7) .95
127 (16.0) 136 (17.4) .48
370 (46.7) 358 (45.9) .75
220 (27.8) 224 (28.7) .68
127 (16.0) 107 (13.7) .20
293 (37.0) 261 (33.5) .14
37 (4.7) 27 (3.5) .23
209 (26.4) 204 (26.2) .92
68 (8.6) 51 (6.5) .13
29 (3.7) 30 (3.8) .85
200 (25.5) 207 (26.5) .56
581 (73.4) 569 (72.9) .86
6 (0.8) 3 (0.4) .32
83 (10.5) 70 (9.0) .31
657 (82.9) 652 (83.5) .74
126 (15.9) 123 (15.8) .94
estive heart failure; COPD, chronic obstructive pulmonary disease; CVA,
, percutaneous coronary intervention.
pensity score-matched infrainguinal bypass group (n 
PTFE conduit Total
184 (23.6%) 366 (46.9%)
77 (9.9%) 322 (41.3%)
9 (1.2%) 92 (11.8%)
270 (34.6%) 780 (100%)harac
, cong, pro
t
)
)
)
)iffer significantly between the two groups (P .2).
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Patients deemed “high risk” because of the presence of
systemic comorbidities are often excluded from being can-
didates for limb salvage through surgical revascularization
and are instead offered major amputation.8 Even among
the dedicated vascular surgical centers participating in the
Bypass versus Angioplasty in Severe Ischaemia of the Leg
(BASIL) trial, for example, a “significant comorbidity pre-
cluding bypass surgery,” excluded 7% of patients with
critical and subcritical limb ischemia from enrollment and
attempts at revascularization.14 Is this a valid reason to
Fig 1. Kaplan-Meier product-limit estimate of 30-day po
patients undergoing major amputation (n  792) or inf
Table IV. A comparison of early postoperative events in t
Variable
Wound disruption
Superficial surgical site infection
Deep incisional surgical site infection
Pneumonia
Unplanned intubation
Deep venous thrombus
Pulmonary embolism
Mechanical ventilation for 48 hours
Progressive renal insufficiency
Acute renal failure
Urinary tract infection
Cardiac arrest requiring cardiopulmonary resuscitation
Myocardial infarction
Bleeding requiring transfusion
Sepsis
Septic shock
Return to the operating room
aP  .05.
bP  .01.exclude patients from revascularization attempts? The de- tision between offering a major amputation or an attempt
t limb salvage through surgical revascularization is often
uite challenging, but remains a fundamental role of the
ascular surgeon in the care of patients with peripheral
ascular disease. Fortunately, many of the other factors
ypically considered in the decision-making process are well
tudied, including the extent of foot necrosis,15,16 location
f the distal target,17 the quality of outflow,18 the availabil-
ty of an adequate vein graft conduit,19 and a patient’s
reoperative functional status and potential for postopera-
ive ambulation20-23 are factors that have been studied in
erative mortality for high-risk, propensity score-matched
inal bypass (n  780).
opensity-matched amputation and bypass cohorts
putation group Bypass group P value
12 (1.5) 17 (2.2) .33
48 (6.1) 55 (7.1) .43
29 (3.7) 31 (4.0) .75
36 (4.5) 30 (3.8) .49
27 (3.4) 39 (5.0) .12
11 (1.4) 9 (1.2) .68
7 (0.9) 0 (0.0) .009b
20 (2.5) 32 (4.1) .08
8 (1.0) 9 (1.2) .78
15 (1.9) 13 (1.7) .73
41 (5.2) 21 (2.7) .01a
15 (1.9) 22 (1.7) .23
8 (1.0) 9 (1.2) .78
7 (0.9) 16 (2.1) .05a
43 (14.1) 44 (5.6) .85
37 (4.7) 35 (4.5) .86
112 (14.1) 215 (27.6) .001bstophe pr
Amhousands of patients over the course of several decades in
h
n
b
s
f
o
h
r
b
b
n
h
s
p
a
s
m
c
w
N
d
e
p
s
a
(
c
g
p
780
JOURNAL OF VASCULAR SURGERY
May 20111256 Barshes et alboth large single-center retrospective studies24 and large
multicenter prospective clinical trials,3,25,26 and the impact
of these factors on patency and limb salvage is well-
documented. Our understanding of the relative periopera-
tive safety (morbidity and mortality) of major amputation
and infrainguinal bypass operations is largely based on
retrospective analyses, but direct comparisons have been
admittedly limited because of the nonrandomized, non-
matched nature of the patient populations (ie, important
and unadjusted differences in the baseline characteristics of
the patient populations that undergo these operations).
Much of the increased perioperative mortality associated
with major amputation has been attributed to this popula-
tion having a higher prevalence of major systemic comor-
bidities than the bypass population (rather than the proce-
dure itself),11 but this is an assumption that has remained
unproven and largely unchallenged.
Our study attempts to examine this assumption and
address the larger question of how systemic comorbidities
might inform the amputation vs revascularization decision-
making process. To accomplish this, we used propensity
score matching to identify cohorts of high-risk patients
undergoingmajor amputation and infrainguinal revascular-
ization. An examination of Table II demonstrates that these
two groups are indeed comparable and clearly supports
their characterization as high risk. In the unmatched pa-
tient population, we found that the 30-day mortality
among the major amputation and infrainguinal bypass
groups were 11.71% and 5.15%, respectively, comparable
to rates seen in large series detailing outcomes after these
Fig 2. Kaplan-Meier product-limit estimate demonstrat
(n  792, black broken line) or infrainguinal bypass (n procedures.3,8,14 In these risk-matched high-risk cohorts, cowever, we found that infrainguinal revascularization was
ot associated with higher 30-day mortality or major mor-
idity thanmajor amputation. Indeed, there was a small but
tatistically significant survival benefit associated with in-
rainguinal bypass (93.46% vs 90.03%; P  .015). The
verall incidence of major complications was similar but
ad a different distribution between the two groups: the
ate of return to the operating room and the need for a
lood transfusion was higher among the patients receiving
ypass and the rate of urinary tract infections and pulmo-
ary emboli (consistent with previous studies27-30) was
igher in the amputation group. Since major amputation
eems no safer than revascularization in these high-risk
atients, the presence of severe systemic comorbidities
lone should not preclude patients from an attempt at
urgical revascularization. Instead, the decision between
ajor amputation and limb salvage through surgical revas-
ularization should be based on patient preference and the
ell-studied, influential factors mentioned above.
One limitation of the American College of Surgeons
SQIP data used in this study may be the variable that
escribes the presence of rest pain or tissue loss. Initial
xamination of this variable showed that only 68% of the
atients that underwent major amputations by vascular
urgeons had rest pain or tissue loss. Although not all
mputations have rest pain or tissue loss as an indication
perhaps as many as 10% are done for reasons other than
ritical limb ischemia9), this surprisingly low number sug-
ested to us that the variable may not perfectly identify all
atients who had critical limb ischemia. To address this
me from operation to discharge for amputation patients
, solid gray line).ing tioncern, we performed a subset analysis with only patients
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addition to excluding patients with complete functional
dependence and those classified as ASA category 5). The
results of this subset analysis were similar to those of the full
analysis incorporating all high-risk patients, including
nearly identical 30-day survival rates. We still feel that the
NSQIP rest pain/tissue loss variable may be lacking sensi-
tivity in identifying the entire critical limb ischemia patient
population; the strikingly similar baseline characteristics
and results obtained for the full and subset analyses seems
to support this and suggests that even the full cohort may
largely be comprised of patients with critical limb ischemia.
However, the limitations of this variable should be kept in
mind for future studies done with American College of
Table V. Comparison of demographic and preoperative ch
(n  505) patients with critical limb ischemia matched by
Variable
A
Age
65 years old
65-74 years old
75-89 years old
90  years old
Race/ethnicity
White
African American
Hispanic
Asian, Native American, other
Male gender
CHF within 30 days before operation
MI within 6 months before operation
Angina within 1 month before operation
Previous PCI
Previous cardiac surgery
Ventilator dependence, preoperatively
Dyspnea at rest
History of severe COPD
Current pneumonia, preoperatively
Serum creatinine 3 mg/dL
Dialysis
Acute renal failure
Non-insulin-dependent diabetes
Insulin-dependent diabetes
History of smoking within 1 year preoperatively
History of CVA with residual deficit
Partial functional dependence before current illness
DNR, preoperatively
Obese (BMI 30 kg/m2)
Chronic steroid use
Weight loss 10% during 6 months before operation
ASA classification
ASA 3
ASA 4
ASA 5
ASA n  E
Anesthetic technique
General anesthesia
Regional anesthesia
ASA, American Society of Anesthesiologists; BMI, body mass index; CHF
cardiovascular accident; DNR, do not resuscitate; MI, myocardial infarctionSurgeons NSQIP data. oThe ASA classification was introduced in the 1960s and
s both well accepted and widely used for estimating peri-
perative risk (we again reiterate that it is perioperative
afety that our study is focused on, not limb outcomes or
ong-term survival). ASA class has been found to be the
actor most strongly predictive of perioperative risk in both
ascular surgery patients31,32 as well as general surgery
atients.33,34 Thus, we feel justified in using this as the
oundation for categorizing patients as high risk. In addi-
ion, we incorporated many of the factors of the RAND
riteria for Surgical Risk (which was also used in the Open
ersus Endovascular Repair trial35) in our definition of
igh risk. We did not consider any of the cardiac risk
lassification schemes that have been used to predict peri-
teristics for high-risk amputation (n  500) and bypass
ensity scoring
tation group No.
(%)
Bypass group No.
(%) P value
72 (34.4) 178 (35.2) .829
43 (28.6) 149 (29.5) .752
68 (33.6) 167 (33.1) .858
17 (3.4) 11 (2.2) .829
14 (62.8) 316 (62.6) .948
23 (24.6) 118 (23.4) .647
26 (5.2) 35 (6.9) .251
37 (7.4) 36 (7.1) .868
14 (62.8) 296 (58.6) .174
52 (10.4) 58 (11.5) .582
43 (8.6) 40 (7.9) .696
12 (2.4) 20 (4.0) .159
97 (19.4) 101 (20.0) .811
76 (35.2) 187 (37.0) .546
1 (0.2) 2 (0.4) .569
40 (8.0) 40 (7.9) .528
88 (17.6) 107 (21.2) .150
8 (1.6) 7 (1.4) .780
77 (35.4) 167 (33.1) .436
81 (36.2) 175 (34.7) .608
20 (4.0) 16 (3.2) .478
72 (14.4) 87 (17.2) .219
46 (49.2) 232 (45.9) .301
36 (27.2) 15.2 (30.1) .310
72 (14.4) 67 (13.3) .603
95 (59.0) 283 (56.0) .342
25 (5.0) 15 (3.0) .100
27 (25.4) 133 (26.3) .735
41 (8.2) 30 (5.9) .162
21 (4.2) 16 (3.2) .385
33 (26.6) 138 (27.3) .851
67 (73.4) 367 (72.7) .795
— — —
39 (7.8) 40 (7.9) .943
02 (80.4) 417 (82.6) .375
93 (18.6) 81 (16.0) .283
estive heart failure; COPD, chronic obstructive pulmonary disease; CVA,
, percutaneous coronary intervention.arac
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May 20111258 Barshes et alinterest was overall mortality. Ultimately, any definition of
risk is, to a degree, arbitrary: risk behaves more as a contin-
uous variable (albeit in a non-linear fashion) than a categor-
ical variable. While the 30-day survival rates of the ampu-
tation and bypass groups may change somewhat as the
definition of “high-risk” changes, it would be unlikely to
influence on the relative risk of mortality between the two
groups and thus would not be likely to change the main
findings of the study or our conclusions.
Another limitation of any nonrandomized study such
as this is the potential for confounding due to unmeasured
variables. For example, ankle-brachial indexes have been
shown to correlate strongly with mortality,36 but were not
available to us in this study. While we have no reason to
suspect that there were large differences between the ankle-
brachial indexes to the amputation and bypass groups, such
a difference may have existed and influenced the mortality
of one groupmore than another. Unfortunately, there is no
way to systematically eliminate the potential for such spec-
ification errors or omitted variable bias short of a random-
ized trial.
Finally, we do not have data on the periprocedural
safety of endovascular interventions for high-risk patients
such as these. A commonly held belief among vascular
surgeons and interventional cardiologists seems to be that
endovascular management is associated with lowermorbid-
ity and mortality. While there are no relevant studies focus-
ing on a high-risk subset of patients, we would point to the
results of the BASIL trial that demonstrated low peripro-
cedural morbidity and mortality rates that did not differ
significantly between angioplasty and surgical bypass for a
Fig 3. Kaplan-Meier product-limit estimate of 30-day po
subset of patients with critical limb ischemia undergoin
505).general population of patients with severe limb ischemia.37hat being said, it is not clear whether certain subgroups of
atients undergoing surgical revascularization may be at
igher risk for perioperative problems, such as patients
aving long operative times because of the need for creat-
ng a composite vein graft or challenging reoperative cases.
In summary, infrainguinal bypass was associated with a
ower 30-day postoperative mortality than major amputa-
ion in the propensity score-matched, high-risk population
f patients in this study. In patients with anatomy suitable
or surgical revascularization and the potential for func-
ional benefit, the presence of severe systemic comorbidities
lone should not preclude infrainguinal bypass as an option
or limb salvage.
The authors thank Grace Fracasso for help with com-
iling relevant Common Procedural Terminology codes
or the study.
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May 20111259.e1 Barshes et alAppendix, online only. Common Procedural
Terminology (CPT) codes used to identify study subjects
“Infrainguinal revascularization” procedures included any of the
following CPT codes:
- Femoropopliteal bypass with vein, prosthetic conduit, or in
situ (CPT codes 35556, 35656, or 35583).
- Femorotibial bypass with vein, prosthetic conduit, or in situ
(CPT codes 35566, 35666, or 35585).
- Distal origin grafts with vein, prosthetic conduits, or in situ
(CPT codes 35570, 35571, 35671, or 35587).
We did not include aortobifemoral bypass, iliofemoral bypass,
femorofemoral bypass, axillofemoral bypass, or any type of
endarterectomy, patch angioplasty, or profundaplasty unless it
was done along with one of the above procedures at the same
operation.
“Major amputation” procedures included any of the following
CPT codes:
- Above-knee amputation (CPT codes 27590 and 27592).
- Below-knee amputation (CPT codes 27880 and 27882).
We did not include what are typically considered “minor”
amputations: ray amputations, transmetatarsal amputations,
